|
|
|
Insider
Information: |
Shah Jaisim |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
176,091 |
|
Indirect Shares
|
221,324 |
|
|
Direct
Value |
$40,392 |
|
|
Indirect Value
|
$327 |
|
|
Total
Shares |
397,415 |
|
|
Total
Value |
$40,719 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PDL Biopharma Inc |
PDLI |
SVP, Mktg & Bus. Affairs |
2008-04-28 |
16,125 |
2004-02-26 |
0 |
Premium* |
|
Sorrento Therapeutics Inc |
SRNE |
Director |
2017-06-15 |
112,633 |
2013-11-25 |
65,442 |
Premium* |
|
Scilex Holding Co |
SCLX |
|
2024-06-20 |
47,333 |
2024-06-20 |
155,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PDLI |
PDL Biopharma Inc |
SVP Mktg & Business Affairs |
|
2006-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
13,940 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2004-04-26 |
4 |
AS |
$27.00 |
$135,000 |
D/D |
(5,000) |
829 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2005-08-03 |
4 |
AS |
$26.10 |
$450,262 |
D/D |
(17,079) |
755 |
|
- |
|
PDLI |
PDL Biopharma Inc |
officerTitle |
|
2006-01-09 |
4 |
AS |
$31.00 |
$155,000 |
D/D |
(5,000) |
1,001 |
|
- |
|
PDLI |
PDL Biopharma Inc |
SR VP, Mkt & Business Affairs |
|
2007-04-11 |
4 |
AS |
$23.00 |
$231,840 |
D/D |
(10,080) |
13,940 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
SR VP, Mkt & Business Affairs |
|
2007-04-13 |
4 |
AS |
$24.00 |
$240,000 |
D/D |
(10,000) |
13,940 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
SR VP, Mkt & Business Affairs |
|
2007-04-23 |
4 |
AS |
$25.00 |
$375,000 |
D/D |
(15,000) |
13,940 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
SR VP, Mkt & Business Affairs |
|
2007-04-30 |
4 |
AS |
$26.00 |
$427,440 |
D/D |
(16,440) |
13,940 |
0 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Director |
|
2013-11-19 |
4 |
B |
$9.00 |
$9,000 |
D/D |
1,000 |
64,442 |
2.39 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Director |
|
2013-11-25 |
4 |
B |
$8.65 |
$8,650 |
I/I |
1,000 |
65,442 |
2.1 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Director |
|
2015-08-03 |
4 |
B |
$11.50 |
$312,674 |
D/D |
27,189 |
92,631 |
2.39 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Director |
|
2017-02-03 |
4 |
B |
$5.15 |
$51,500 |
D/D |
10,000 |
102,631 |
2.39 |
- |
|
SRNE |
Sorrento Therapeutics Inc |
Director |
|
2017-06-15 |
4 |
B |
$1.79 |
$17,904 |
D/D |
10,002 |
112,633 |
2.39 |
- |
|
SCLX |
Scilex Holding Co |
See Remarks |
|
2024-05-16 |
4 |
B |
$0.84 |
$69,846 |
I/I |
83,061 |
98,943 |
0.01 |
- |
|
SCLX |
Scilex Holding Co |
See Remarks |
|
2024-05-17 |
4 |
B |
$0.92 |
$52,099 |
I/I |
56,939 |
155,882 |
0.01 |
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2004-02-18 |
4 |
OE |
$12.29 |
$61,450 |
D/D |
5,000 |
5,829 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2004-02-26 |
4/A |
OE |
$12.29 |
$2,458 |
D/D |
200 |
1,029 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2004-02-26 |
4 |
OE |
$12.29 |
$3,687 |
D/D |
300 |
1,129 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2004-03-05 |
4 |
OE |
$12.29 |
$58,992 |
D/D |
4,800 |
5,629 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2004-04-26 |
4 |
OE |
$12.29 |
$61,450 |
D/D |
5,000 |
5,829 |
|
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, Marketing |
|
2005-08-03 |
4 |
OE |
$12.29 |
$201,800 |
D/D |
16,250 |
6,584 |
|
- |
|
PDLI |
PDL Biopharma Inc |
officerTitle |
|
2006-01-09 |
4 |
OE |
$12.29 |
$61,450 |
D/D |
5,000 |
6,001 |
|
- |
|
PDLI |
PDL Biopharma Inc |
SR VP, Mkt & Business Affairs |
|
2007-04-11 |
4 |
OE |
$7.83 |
$82,884 |
D/D |
10,080 |
19,437 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
SR VP, Mkt & Business Affairs |
|
2007-04-13 |
4 |
OE |
$8.55 |
$95,128 |
D/D |
10,000 |
15,687 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
SR VP, Mkt & Business Affairs |
|
2007-04-23 |
4 |
OE |
$12.29 |
$214,822 |
D/D |
15,000 |
22,354 |
0 |
- |
|
33 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|